Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An integrated genomic, transcriptional and protein investigation of FGFRL1 as a putative 4p16.3 deletion target in bladder cancer.

Genes, chromosomes & cancer - 1 Sept 2013

di Martino Erica, Taylor Claire F, Roulson Jo-An, Knowles Margaret A

Abstract excerpt

Loss of heterozygosity (LOH) of chromosome arm 4p is a common event in bladder and other malignancies. At least three distinct regions of deletion have been identified, but the deletion targets have so far remained elusive. In this study, we have identified a novel region of deletion mapping to 4...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosomes, Human, Pair 4
Share to Down-Regulation
Share to Genes, Tumor Suppressor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Loss of Heterozygosity

Share to Receptor, Fibroblast Growth Factor, Type 3

Share to Sequence Deletion

Share to Urinary Bladder Neoplasms

Share to Urothelium

Source

Identifiers

PMID: 23775577
DOI: 10.1002/gcc.22082

Genes

FGFRL1
FGFR3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23775577-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An integrated genomic, transcriptional and protein investigation of FGFRL1 as a putative 4p16.3 deletion target in bladder cancer.PMID 23775577Read ↗

Loss of GRLF1 induces aneuploidy and enhances bladder cancer cell migration and invasion by modulating actin dynamicsSemantic proximity Read ↗

Tumor suppressor loci in bladder cancer.Semantic proximity Read ↗

LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer.Semantic proximity Read ↗

Identification of novel bladder tumour suppressor genes.Semantic proximity Read ↗

Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development.Semantic proximity Read ↗

Loss of heterozygosity and DNA methylation affect germline fibroblast growth factor receptor 4 polymorphism to direct allelic selection in breast cancer.Semantic proximity Read ↗

[Update on FGFR3 mutation and multiple regional epigenetic silencing (MRES) phenotype in urothelial carcinogenesis].Semantic proximity Read ↗

High-resolution whole-organ mapping with SNPs and its significance to early events of carcinogenesis.Semantic proximity Read ↗

KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer.Semantic proximity Read ↗

Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer.Semantic proximity Read ↗

CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma.Semantic proximity Read ↗

Deletion mapping of chromosome 11 in carcinoma of the bladder.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.